#BEGIN_DRUGCARD DB01717

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H29N10O22P5

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Bis(Adenosine)-5'-Pentaphosphate

# HET_ID:
AP5

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-53(35,36)49-55(39,40)51-57(43,44)52-56(41,42)50-54(37,38)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13+,14+,19+,20+/m0/s1

# InChI_Key:
InChIKey=OIMACDRJUANHTJ-APSSSFQSSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1717

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
916.3669

# Molecular_Weight_Mono:
916.014595222

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1ZIN

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.2

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
6.92e+00 g/l

# Primary_Accession_No:
DB01717

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6419780

# PubChem_Substance_ID:
46505205

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00535

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)OP(O)(=O)O[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]2O[C@H]([C@H](O)[C@H]2O)N2C=NC3=C2N=CN=C3N)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:25 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D00619

# Drug_Target_1_GenBank_ID_Protein:
216340

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
adk

# Drug_Target_1_Gene_Sequence:
>654 bp
ATGAACTTAGTCTTAATGGGGCTTCCTGGTGCCGGTAAAGGCACACAGGGCGAACGAATT
GTTGAGGATTATGGGATTCCTCATATCTCAACAGGAGATATGTTCCGTGCTGCTATGAAA
GAAGAAACACCACTCGGACTCGAAGCAAAATCTTATATTGATAAGGGAGAGCTCGTACCT
GACGAAGTCACAATCGGAATTGTAAAAGAGAGACTTGGCAAAGATGATTGTGAAAGAGGT
TTTCTTCTGGACGGATTTCCGCGAACAGTCGCTCAAGCCGAAGCTCTTGAAGAAATTCTT
GAGGAATACGGCAAGCCGATTGATTATGTCATTAACATTGAAGTCGACAAAGATGTTCTG
ATGGAACGTCTGACTGGACGCAGAATTTGCAGTGTTTGCGGCACAACCTATCATTTAGTC
TTTAATCCGCCGAAAACGCCGGGTATTTGTGATAAAGACGGAGGCGAACTCTATCAACGG
GCAGATGATAATGAGGAAACAGTCTCTAAACGGCTTGAGGTAAACATGAAGCAAACTCAG
CCTTTACTCGATTTCTATTCAGAGAAAGGTTATCTTGCAAACGTGAATGGCCAGCAGGAC
ATTCAAGACGTTTATGCAGATGTGAAGGATCTTCTTGGAGGATTAAAAAAATGA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
1554691	Glaser P, Presecan E, Delepierre M, Surewicz WK, Mantsch HH, Barzu O, Gilles AM: Zinc, a novel structural element found in the family of bacterial adenylate kinases. Biochemistry. 1992 Mar 31;31(12):3038-43.
2110998	Suh JW, Boylan SA, Thomas SM, Dolan KM, Oliver DB, Price CW: Isolation of a secY homologue from Bacillus subtilis: evidence for a common protein export pathway in eubacteria. Mol Microbiol. 1990 Feb;4(2):305-14.
2113521	Nakamura K, Nakamura A, Takamatsu H, Yoshikawa H, Yamane K: Cloning and characterization of a Bacillus subtilis gene homologous to E. coli secY. J Biochem (Tokyo). 1990 Apr;107(4):603-7.
2139212	Yoshikawa H, Doi RH: Sequence of the Bacillus subtilis spectinomycin resistance gene region. Nucleic Acids Res. 1990 Mar 25;18(6):1647.
8635744	Suh JW, Boylan SA, Oh SH, Price CW: Genetic and transcriptional organization of the Bacillus subtilis spc-alpha region. Gene. 1996 Feb 22;169(1):17-23.
9298659	Antelmann H, Bernhardt J, Schmid R, Mach H, Volker U, Hecker M: First steps from a two-dimensional protein index towards a response-regulation map for Bacillus subtilis. Electrophoresis. 1997 Aug;18(8):1451-63.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2284

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
24120

# Drug_Target_1_Name:
Adenylate kinase

# Drug_Target_1_Number_of_Residues:
217

# Drug_Target_1_PDB_ID:
1P3J

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00406	ADK
PF05191	ADK_lid

# Drug_Target_1_Protein_Sequence:
>Adenylate kinase
MNLVLMGLPGAGKGTQGERIVEDYGIPHISTGDMFRAAMKEETPLGLEAKSYIDKGELVP
DEVTIGIVKERLGKDDCERGFLLDGFPRTVAQAEALEEILEEYGKPIDYVINIEVDKDVL
MERLTGRRICSVCGTTYHLVFNPPKTPGICDKDGGELYQRADDNEETVSKRLEVNMKQTQ
PLLDFYSEKGYLANVNGQQDIQDVYADVKDLLGGLKK

# Drug_Target_1_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This small ubiquitous enzyme is essential for maintenance and cell growth

# Drug_Target_1_SwissProt_ID:
P16304

# Drug_Target_1_SwissProt_Name:
KAD_BACSU

# Drug_Target_1_Synonyms:
AK
ATP-AMP transphosphorylase
EC 2.7.4.3
SOI16
Superoxide-inducible protein 16

# Drug_Target_1_Theoretical_pI:
4.38

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M88104

# Drug_Target_2_GenBank_ID_Protein:
142446

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
adk

# Drug_Target_2_Gene_Sequence:
>654 bp
ATGAATTTAGTGCTGATGGGGCTGCCGGGTGCCGGCAAAGGCACGCAGGCCGAGAAAATC
GTAGCGGCTTACGGTATTCCGCACATTTCAACGGGCGATATGTTTCGGGCGGCGATGAAG
GAAGGAACGCCGCTAGGGCTTCAAGCGAAGCAATATATGGACCGCGGCGACCTTGTTCCG
GATGAAGTGACGATCGGCATTGTCCGTGAACGGCTGAGCAAAGACGATTGCCAAAACGGT
TTTTTGCTCGATGGATTCCCGCGCACGGTCGCTCAAGCGGAGGCGCTGGAAACGATGTTG
GCCGACATTGGCCGCAAACTTGACTATGTCATCCATATCGATGTCCGCCAAGACGTTTTA
ATGGAGCGCTTGACCGGCAGACGGATTTGCCGCAACTGCGGAGCGACGTACCATCTTATT
TTTCATCCGCCGGCGAAACCGGGTGTTTGCGATAAGTGCGGGGGGGAATTGTACCAGCGC
GCCGATGATAACGAAGCGACAGTGGCGAACCGGCTCGAAGTGAATATGAAACAAATGAAG
CCGCTCGTTGACTTTTACGAACAAAAAGGCTATTTGCGCAACATTAACGGCGAACAGGAC
ATGGAAAAGGTGTTTGCCGATATTCGTGAATTGCTCGGGGGACTTGCTCGATGA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
1554691	Glaser P, Presecan E, Delepierre M, Surewicz WK, Mantsch HH, Barzu O, Gilles AM: Zinc, a novel structural element found in the family of bacterial adenylate kinases. Biochemistry. 1992 Mar 31;31(12):3038-43.
9715904	Berry MB, Phillips GN Jr: Crystal structures of Bacillus stearothermophilus adenylate kinase with bound Ap5A, Mg2+ Ap5A, and Mn2+ Ap5A reveal an intermediate lid position and six coordinate octahedral geometry for bound Mg2+ and Mn2+. Proteins. 1998 Aug 15;32(3):276-88.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2311

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
24143

# Drug_Target_2_Name:
Adenylate kinase

# Drug_Target_2_Number_of_Residues:
217

# Drug_Target_2_PDB_ID:
1ZIP

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00406	ADK
PF05191	ADK_lid

# Drug_Target_2_Protein_Sequence:
>Adenylate kinase
MNLVLMGLPGAGKGTQAEKIVAAYGIPHISTGDMFRAAMKEGTPLGLQAKQYMDRGDLVP
DEVTIGIVRERLSKDDCQNGFLLDGFPRTVAQAEALETMLADIGRKLDYVIHIDVRQDVL
MERLTGRRICRNCGATYHLIFHPPAKPGVCDKCGGELYQRADDNEATVANRLEVNMKQMK
PLVDFYEQKGYLRNINGEQDMEKVFADIRELLGGLAR

# Drug_Target_2_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. This small ubiquitous enzyme involved in the energy metabolism and nucleotide synthesis, is essential for maintenance and cell growth

# Drug_Target_2_SwissProt_ID:
P27142

# Drug_Target_2_SwissProt_Name:
KAD_GEOSE

# Drug_Target_2_Synonyms:
AK
ATP-AMP transphosphorylase
EC 2.7.4.3

# Drug_Target_2_Theoretical_pI:
6.13

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
Not Available

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Nucleotide transport and metabolism

# Drug_Target_3_General_References:
Not Available

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2312

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
23889

# Drug_Target_3_Name:
Adenylate kinase

# Drug_Target_3_Number_of_Residues:
217

# Drug_Target_3_PDB_ID:
1S3G

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00406	ADK
PF05191	ADK_lid

# Drug_Target_3_Protein_Sequence:
>Adenylate kinase
MNIVLMGLPGAGKGTQADRIVEKYGTPHISTGDMFRAAIQEGTELGVKAKSFMDQGALVP
DEVTIGIVRERLSKSDCDNGFLLDGFPRTVPQAEALDQLLADMGRKIEHVLNIQVEKEEL
IARLTGRRICKVCGTSYHLLFNPPQVEGKCDKDGGELYQRADDNPDTVTNRLEVNMNQTA
PLLAFYDSKEVLVNINGQKDIKDVFKDLDVILQGNGQ

# Drug_Target_3_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. This small ubiquitous enzyme involved in the energy metabolism and nucleotide synthesis, is essential for maintenance and cell growth

# Drug_Target_3_SwissProt_ID:
P84139

# Drug_Target_3_SwissProt_Name:
KAD_BACGO

# Drug_Target_3_Synonyms:
AK
ATP-AMP transphosphorylase
EC 2.7.4.3

# Drug_Target_3_Theoretical_pI:
4.74

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
Not Available

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
AK2

# Drug_Target_4_Gene_Sequence:
Not Available

# Drug_Target_4_General_Function:
Not Available

# Drug_Target_4_General_References:
Not Available

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6987

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
Not Available

# Drug_Target_4_Name:
Adenylate kinase 2, mitochondrial

# Drug_Target_4_Number_of_Residues:
0

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Adefovir Dipivoxil Pathway	SMP00418
Tenofovir Pathway	SMP00419

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
Not Available

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
Not Available

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
P54819

# Drug_Target_4_SwissProt_Name:
KAD2_HUMAN

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
Not Available

# Drug_Target_4_Transmembrane_Regions:
Not Available

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
AK8

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
7046

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Putative adenylate kinase-like protein C9orf98

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q96MA6

# Drug_Target_5_SwissProt_Name:
KAD8_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Cytoplasm

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X03038

# Drug_Target_6_GenBank_ID_Protein:
40904

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
adk

# Drug_Target_6_Gene_Sequence:
>645 bp
ATGCGTATCATTCTGCTTGGCGCTCCGGGCGCGGGGAAAGGGACTCAGGCTCAGTTCATC
ATGGAGAAATATGGTATTCCGCAAATCTCCACTGGCGATATGCTGCGTGCTGCGGTCAAA
TCTGGCTCCGAGCTGGGTAAACAAGCAAAAGACATTATGGATGCTGGCAAACTGGTCACC
GACGAACTGGTGATCGCGCTGGTTAAAGAGCGCATTGCTCAGGAAGACTGCCGTAATGGT
TTCCTGTTGGACGGCTTCCCGCGTACCATTCCGCAGGCAGACGCGATGAAAGAAGCGGGC
ATCAATGTTGATTACGTTCTGGAATTCGACGTACCGGACGAACTGATCGTTGACCGTATC
GTCGGTCGCCGCGTTCATGCGCCGTCTGGTCGTGTTTATCACGTTAAATTCAATCCGCCG
AAAGTAGAAGGCAAAGACGACGTTACCGGTGAAGAACTGACTACCCGTAAAGATGATCAG
GAAGAGACCGTACGTAAACGTCTGGTTGAATACCATCAGATGACAGCACCGCTGATCGGC
TACTACTCCAAAGAAGCAGAAGCGGGTAATACCAAATACGCGAAAGTTGACGGCACCAAG
CCGGTTGCTGAAGTTCGCGCTGATCTGGAAAAAATCCTCGGCTAA

# Drug_Target_6_General_Function:
Nucleotide transport and metabolism

# Drug_Target_6_General_References:
1548697	Muller CW, Schulz GE: Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state. J Mol Biol. 1992 Mar 5;224(1):159-77.
2051480	Miyamoto K, Nakahigashi K, Nishimura K, Inokuchi H: Isolation and characterization of visible light-sensitive mutants of Escherichia coli K12. J Mol Biol. 1991 Jun 5;219(3):393-8.
2223776	Reinstein J, Schlichting I, Wittinghofer A: Structurally and catalytically important residues in the phosphate binding loop of adenylate kinase of Escherichia coli. Biochemistry. 1990 Aug 14;29(32):7451-9.
2844237	Reinstein J, Brune M, Wittinghofer A: Mutations in the nucleotide binding loop of adenylate kinase of Escherichia coli. Biochemistry. 1988 Jun 28;27(13):4712-20.
2997739	Brune M, Schumann R, Wittinghofer F: Cloning and sequencing of the adenylate kinase gene (adk) of Escherichia coli. Nucleic Acids Res. 1985 Oct 11;13(19):7139-51.
3299380	Bardwell JC, Craig EA: Eukaryotic Mr 83,000 heat shock protein has a homologue in Escherichia coli. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5177-81.
7937733	Berry MB, Meador B, Bilderback T, Liang P, Glaser M, Phillips GN Jr: The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP. Proteins. 1994 Jul;19(3):183-98.
8451239	Muller CW, Schulz GE: Crystal structures of two mutants of adenylate kinase from Escherichia coli that modify the Gly-loop. Proteins. 1993 Jan;15(1):42-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9600841	Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol. 1998 May 8;278(3):599-608.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2296

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
23586

# Drug_Target_6_Name:
Adenylate kinase

# Drug_Target_6_Number_of_Residues:
214

# Drug_Target_6_PDB_ID:
2ECK

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00406	ADK
PF05191	ADK_lid

# Drug_Target_6_Protein_Sequence:
>Adenylate kinase
MRIILLGAPGAGKGTQAQFIMEKYGIPQISTGDMLRAAVKSGSELGKQAKDIMDAGKLVT
DELVIALVKERIAQEDCRNGFLLDGFPRTIPQADAMKEAGINVDYVLEFDVPDELIVDRI
VGRRVHAPSGRVYHVKFNPPKVEGKDDVTGEELTTRKDDQEETVRKRLVEYHQMTAPLIG
YYSKEAEAGNTKYAKVDGTKPVAEVRADLEKILG

# Drug_Target_6_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. This small ubiquitous enzyme involved in the energy metabolism and nucleotide synthesis, is essential for maintenance and cell growth

# Drug_Target_6_SwissProt_ID:
P69441

# Drug_Target_6_SwissProt_Name:
KAD_ECOLI

# Drug_Target_6_Synonyms:
AK
ATP-AMP transphosphorylase
EC 2.7.4.3

# Drug_Target_6_Theoretical_pI:
5.45

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasm

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
AK1

# Drug_Target_7_GenBank_ID_Gene:
J04809

# Drug_Target_7_GenBank_ID_Protein:
178322

# Drug_Target_7_GeneCard_ID:
AK1

# Drug_Target_7_Gene_Name:
AK1

# Drug_Target_7_Gene_Sequence:
>585 bp
ATGGAAGAGAAGCTGAAGAAAACCAAGATCATCTTTGTGGTGGGTGGGCCTGGCTCAGGG
AAGGGCACCCAGTGTGAGAAGATCGTGCAGAAGTATGGCTACACCCACCTCTCCACCGGG
GACCTCCTGCGGTCCGAGGTCAGCTCAGGCTCGGCCAGGGGCAAGAAGCTGTCGGAAATC
ATGGAGAAGGGGCAGCTGGTTCCACTGGAGACAGTGTTGGACATGCTCCGGGATGCCATG
GTGGCCAAAGTCAATACTTCCAAAGGCTTCCTGATTGATGGCTACCCGCGGGAGGTGCAG
CAAGGAGAAGAGTTTGAGCGACGGATTGGACAGCCCACACTGCTGCTGTATGTGGACGCA
GGCCCTGAGACCATGACCCAGCGGCTCTTGAAACGTGGAGAGACCAGCGGGCGTGTGGAC
GACAATGAGGAGACCATCAAAAAGCGGCTGGAGACCTATTACAAGGCCACAGAACCCGTC
ATCGCCTTCTATGAGAAACGTGGCATTGTGCGCAAGGTCAACGCTGAGGGCTCCGTGGAC
AGTGTCTTCTCCCAGGTCTGCACCCACCTGGACGCCCTAAAGTAG

# Drug_Target_7_General_Function:
Nucleotide transport and metabolism

# Drug_Target_7_General_References:
183954	Von Zabern I, Wittmann-Liebold B, Untucht-Grau R, Schirmer RH, Pai EF: Primary and tertiary structure of the principal human adenylate kinase. Eur J Biochem. 1976 Sep;68(1):281-90.
2542324	Matsuura S, Igarashi M, Tanizawa Y, Yamada M, Kishi F, Kajii T, Fujii H, Miwa S, Sakurai M, Nakazawa A: Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of the cytosolic adenylate kinase. J Biol Chem. 1989 Jun 15;264(17):10148-55.

# Drug_Target_7_HGNC_ID:
HGNC:361

# Drug_Target_7_HPRD_ID:
00046

# Drug_Target_7_ID:
2323

# Drug_Target_7_Locus:
9q34.1

# Drug_Target_7_Molecular_Weight:
21635

# Drug_Target_7_Name:
Adenylate kinase isoenzyme 1

# Drug_Target_7_Number_of_Residues:
194

# Drug_Target_7_PDB_ID:
1Z83

# Drug_Target_7_Pathway:
Adefovir Dipivoxil Pathway	SMP00418
Tenofovir Pathway	SMP00419

# Drug_Target_7_Pfam_Domain_Function:
PF00406	ADK

# Drug_Target_7_Protein_Sequence:
>Adenylate kinase isoenzyme 1
MEEKLKKTKIIFVVGGPGSGKGTQCEKIVQKYGYTHLSTGDLLRSEVSSGSARGKKLSEI
MEKGQLVPLETVLDMLRDAMVAKVNTSKGFLIDGYPREVQQGEEFERRIGQPTLLLYVDA
GPETMTQRLLKRGETSGRVDDNEETIKKRLETYYKATEPVIAFYEKRGIVRKVNAEGSVD
SVFSQVCTHLDALK

# Drug_Target_7_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
This small ubiquitous enzyme is essential for maintenance and cell growth

# Drug_Target_7_SwissProt_ID:
P00568

# Drug_Target_7_SwissProt_Name:
KAD1_HUMAN

# Drug_Target_7_Synonyms:
AK1
ATP-AMP transphosphorylase
EC 2.7.4.3
Myokinase

# Drug_Target_7_Theoretical_pI:
8.99

# Drug_Target_7_Transmembrane_Regions:
None

#END_DRUGCARD DB01717
